ArticleCureus2025
Hemophagocytic Lymphohistiocytosis Secondary to Epstein-Barr Virus Infection in an Adolescent Male Patient: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a severe hematological condition characterized by a wide spectrum of clinical presentations, making diagnosis particularly challenging. Potential triggers include infections, malignancies, autoimmune diseases, and certain medications or interventions. We report a case of HLH in an adolescent male in his late teens triggered by Epstein-Barr virus infection. The initial symptoms were malaise, jaundice, and bilateral hearing loss. On examination, the patient had palpable cervical lymphadenopathy, splenomegaly, and epigastric tenderness. Laboratory investigations showed pancytopenia with elevated ferritin and triglyceride levels. The patient was transferred from a district general hospital to the nearest tertiary center and subsequently admitted to the intensive care unit. Bone marrow and lymph node biopsies were performed to exclude lymphoma. He was successfully treated with methylprednisolone, anakinra (interleukin-1 receptor antagonist), and intravenous immunoglobulin, resulting in marked improvement in symptoms, viral load, and biochemical parameters.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.